SHANNON NOBLES: Open Payments
NPI 1447702667 · SAYRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Alkermes, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $28 |
Products named: VRAYLAR, CAPLYTA, FANAPT, LYBALVI, UZEDY, INGREZZA, COBENFY, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
